A new longitudinal study provides critical insights into the intricate interplay between human immunity and viral evolution ...

We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a ...

Pediatric COVID-19 severity appears to be declining among hospitalized children as Omicron subvariants evolve.

The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...

A UBC-led team of researchers has discovered two chemical compounds with potent and wide-ranging antiviral activity that ...

Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Moderna’s updated COVID-19 mRNA vaccine, Spikevax targeting the SARS-CoV-2 LP.8.1 variant, for adults and children aged ...

Sustained protection through 6 months, but effectiveness slipped as newer strains emerged ...

Two major trials show metformin taken during acute COVID-19 lowers long COVID risk, is safe, and could be added to outpatient ...